Wizz Air Abu Dhabi launches price alert in app tradearabia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tradearabia.com Daily Mail and Mail on Sunday newspapers.
Direct News Source
Expedia Group Releases Trends and Predictions for 2021
New report finds people plan to travel more once a COVID-19 vaccine is widely available and will extend vacations this year, signaling industry recovery
Today, Expedia Group released its 2021 Travel Trends Report, highlighting the critical role travel will play in bringing people together following nearly a year of relative isolation. The report contains findings from a study of 2,200 Americans in partnership with data intelligence firm Morning Consult, which explored how COVID-19 has influenced trip plans and the way consumers feel about travel in the year ahead. In combination with proprietary data from Brand Expedia®, Expedia Group™ Media Solutions, Travelocity®, and Vrbo®, the report provides a broad outlook on travel and industry recovery in 2021.
Cracker Barrel and P tit Quebec brands. The Blue Cow will now appear on more than 55 additional products under the Astro and Stonyfield yogurt brands. Lactalis Canada will also feature the logo on the company s digital advertising and in-store (point-of-sale) signage. The Blue Cow is widely recognized as a symbol of dairy farmers dedication and pride in producing 100% high-quality Canadian milk, and their high standards in the areas of animal care, food safety, milk quality and sustainable production, said Pierre Lampron, President of Dairy Farmers of Canada. As one of the largest processors in Canada, Lactalis Canada s decision to feature the logo on Astro and Stonyfield yogurts speaks volumes about the trust consumers, processors and retailers have in our practices, and we are thrilled to expand our partnership further.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Nyxoah receives FDA approval for full-body 1.5T and 3T MRI compatibility for the Genio® system .
NyxoahFebruary 9, 2021 GMT
PRESS RELEASE
Nyxoah receives FDA approval for full-body 1.5T and 3T MRI compatibility for the Genio® system to treat Obstructive Sleep Apnea (OSA)
Mont-Saint-Guibert, Belgium – 9th February 2021 – Nyxoah SA (Euronext: NYXH) (“Nyxoah” or the “Company”), a health-technology company focused on the development and commercialization of innovative solutions and services to treat Obstructive Sleep Apnea (OSA), today announces that the Company has received approval by the Food and Drug Administration (FDA) for the Magnetic Resonance Imaging (MRI) conditional labeling for the Genio® neurostimulation-based OSA therapy, currently being evaluated in the DREAM pivotal IDE study.